ArticleMolecular cancer therapeutics2020

Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy.

Maike Zimmermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.